InvestorsHub Logo
Followers 95
Posts 11590
Boards Moderated 0
Alias Born 12/27/2011

Re: Aggie14 post# 16354

Saturday, 03/25/2017 1:28:34 PM

Saturday, March 25, 2017 1:28:34 PM

Post# of 37495
Just a few observations...

1.) We still know surprisingly little about their business plan. We've only seen one PR from the CEO and it was pretty vague. Hopefully, we'll be seeing a PR this week.

2.) The shares outstanding for the past quarter has been listed as 1,130,651,683. The new 10-Q now says it is 975,828,741 as of March 4. Despite Bubba's constant claims of imminent dilution, there was actually a reduction of 154,822,942 shares. From the 10-Q...

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

In the three months ended January 31, 2017, we have not issued any shares of stock.



Consequently, the share of ownership (and thus the value) of the shares we own has gone up.

3.) From the perspective of previous owners of VitaCig, we now have net income year to date of $915,480 vs a loss a year ago of $110,657. Total stockholder equity is $3,221,647 vs a negative $132,192 last year.

4.) Earnings Per Share (EPS), assuming there is zero profit for the current quarter, would be $.0009 (EPS is calculated on annual numbers). Consequently, OMHE is currently trading at roughly 33 PE (Price Earnings Ratio) and this is a very rational level for a growth company.

5.) There has been a minor operating loss of $165,693, but this has been the result of $424,945 in consulting fees associated with Malecon's evolution into a public company and development of a new business plan.

6.) We're still waiting for specifics on the business plan going forward. Will there be a restructuring of the share structure? How will growth be achieved for the rest of this calendar year? Hopefully, we'll get some answers soon.




Les